Drug Patent Watch

DECEMBER 17, 2024

Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. Today, they’re strategic partners in drug development and manufacturing, offering end-to-end solutions that can make or break a pharmaceutical company’s success.

Manufacturing 90

Manufacturing Production Development Big Data 90

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing 96

Licensing Licensing Branding Drugs 96

Pharma Marketing Network

AUGUST 18, 2021

SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. Marketing Agility – the Path to Digital Engagement & Innovation. But as an industry, we’re still not moving fast enough, particularly when it comes to digital marketing. 16th appeared first on Pharma Marketing Network.

Marketing 98

Marketing Big Data Life Science Branding 98

Pharmaceutical Technology

OCTOBER 27, 2022

Belfast startup AMPLY has raised £900,000 to develop a range of new products that hopes to tackle multi-drug resistent pathogens using its artificial intelligence (AI) drug discovery platform. The funding round comes as medtech funding has increased over the past decade, according to new data from GlobalData, accessed on September 22.

Drugs 147

Drugs Big Data Bacteria Development 147

Roots Analysis

JANUARY 28, 2024

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

XTalks

SEPTEMBER 9, 2024

This blog provides a comprehensive look at the medical device giants, ranked by market capitalization , leading the charge into the future of medicine. Abbott Laboratories (ABT) Market Capitalization : $267.1 Billion Abbott Laboratories leads the medical device industry in market capitalization. In Q2 2024, Intuitive posted $2.01

Marketing 105

Marketing Insulin Sales Big Data 105

Drug Patent Watch

JANUARY 16, 2025

Real-Time Assessment and Strategic Planning AI and big data are also enabling real-time assessment of patent filing trends across technologies, geographies, and industries. Tools like PatSeer and Derwent Innovation offer extensive data integration capabilities, allowing for more thorough and comprehensive patent searches.

Big Data 52

Big Data Engineer Marketing Development 52

Pharma Marketing Network

JANUARY 29, 2025

Marketers must adapt to cutting-edge technology, personalized engagement, and regulatory shifts to stay ahead. But what exactly is shaping the future of pharma marketing this year? With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns.

Marketing 52

Marketing Compliance Big Data Branding 52

Pharmaceutical Technology

AUGUST 2, 2022

This may be tied to a previous finding derived from the same survey, highlighting that Spain and the UK had the highest percentage of respondents using 'all-electronic' patient records compared with the other surveyed European markets (France, Germany and Italy—Figure 2).

Big Data 162

Big Data Clinical Research Research Marketing 162

pharmaphorum

DECEMBER 8, 2022

However, such advancements, while transforming patients’ lives, are fueling an increasingly complex market landscape characterized by smaller and harder‑to‑reach patient populations, complicated diagnostic processes, and significant and fragmented pockets of high unmet need.

Big Data 96

Big Data Gene Therapy Medicine Marketing 96

pharmaphorum

DECEMBER 14, 2020

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development.

Development 52

Development Drugs Big Data Genome 52

XTalks

AUGUST 21, 2020

Michel Nielen, professor of food safety at Wageningen University & Research, in the Netherlands wanted to create a fundamental change in the world of food monitoring, so he and his team coordinated the FoodSmartphone project which is developing ways to detect food quality and safety using smartphones. Predicting Fraud. Traceability.

Regulation 110

Regulation Big Data Contamination Production 110

Pharma Marketing Network

OCTOBER 14, 2024

As the landscape evolves, pharma executives must adapt their marketing strategies to remain competitive and effectively reach their target audiences. The rise of big data analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing.

Marketing 52

Marketing Branding Big Data Drugs 52

Pharma Marketing Network

NOVEMBER 11, 2020

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. These changes include marketing processes, customer engagement, tools and tactics. .

Marketing 52

Marketing Doctor Doctors Branding 52

pharmaphorum

FEBRUARY 1, 2022

His research focuses on the development of big data machine learning for tracking the health of complex systems. He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

Roots Analysis

APRIL 4, 2023

Machine learning is one of the essential concepts that has significantly driven progress in the development of artificial intelligence. In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment.

Big Data 52

Big Data Life Science Development Clinical Trials 52

Delveinsight

AUGUST 18, 2021

percent of the population (approximately 5 million people) are at increased risk of Type 2 Diabetes with an HbA1c ( as per the Diabetes UK, based on data from the Health Survey for England). Several genetic and lifestyle factors are observed to be the factors for the development of Type 2 diabetes. Similarly, in the UK, around 10.7

Insulin 94

Insulin Marketing Development Drugs 94

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This will also allow companies to utilize advanced computational models to find better treatments more quickly while also reducing costs associated with drug development.

Clinical Trials 52

Clinical Trials Clinical Trials Big Data Life Science 52

XTalks

MARCH 12, 2025

This 4th issue aims to provide industry stakeholders with the knowledge they need to stay ahead of the curve and leverage the latest innovations to enhance efficiency, improve patient outcomes and accelerate the development of life-changing therapies.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation. Ray Gomez , Head, Worldwide Digital Marketing – Channel & Content Strategy, BD.

Big Data 52

Big Data Marketing Life Science Licensing 52

pharmaphorum

FEBRUARY 11, 2022

Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

SEPTEMBER 18, 2020

German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

XTalks

JANUARY 20, 2022

The career outlook for life science consulting is promising as the size of the consulting market worldwide was $132 billion in 2020, according to the Statista Research Department. Product development: In this area, a consultant helps a client launch a new product.

Life Science 98

Life Science Production Marketing Big Data 98

Pharmaceutical Technology

NOVEMBER 9, 2022

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. Visibility that’s not accessible in real time isn’t really visibility at all.

Big Data 130

Big Data Manufacturing Vaccination Vaccine 130

Intouch Solutions

FEBRUARY 1, 2022

Digital health investments skyrocketed in 2021, increasing 79% from 2020, according to a year-end report by CB Insights , a marketing intelligence firm. There is still vast potential to connect wearable data, remote monitoring, and virtual care to improve patient outcomes. Author: Alex Kareotes, Director, Media and Innovation.

Branding 98

Branding Marketing Big Data Clinical Trials 98

pharmaphorum

OCTOBER 26, 2021

Using big data and artificial intelligence would give the manufacturing sector the ability to improve accuracy and eliminate errors, while also increasing the transparency of supply chains. “In Unfortunately, in Europe today, we are far from having an ecosystem that properly recognises this type of innovation.”. “We

Manufacturing 121

Manufacturing Medicine Big Data Development 121

pharmaphorum

APRIL 8, 2022

Dennis Kadioglu is the deputy head of both the Medical Informatics Group (MIG) and the Data Integration Center (DIC) at the University Hospital Frankfurt in Frankfurt am Main. Josef Schepers is deputy director of the Core Unit E-Health and Interoperability within Berlin Institute of Health at Charité – Universitätsmedizin Berlin.

Genome 78

Genome Genomics Research Big Data 78

Cloudbyz

SEPTEMBER 25, 2020

HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. The Global Startup Heat Map below highlights 5 startups & emerging companies developing pharmacovigilance solutions. Clinical trials play a pivotal role in drug development. MEDIKURA Digital Health – Post-Market Drug Safety.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

Roots Analysis

FEBRUARY 7, 2023

AI has demonstrated potential in improving tumor imaging diagnosis and therapy response evaluation, anticipating clinical outcomes, and accelerating drug development and translational oncology. The market is characterized by a mix of well-established and small firms.

Marketing 40

Marketing Big Data Development Drugs 40

Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation. Ray Gomez , Head, Worldwide Digital Marketing – Channel & Content Strategy, BD.

Big Data 40

Big Data Marketing Life Science Licensing 40

pharmaphorum

OCTOBER 16, 2020

With large datasets crucial to gaining an understanding of rare diseases and opening the door to drug development, digital technology is proving transformative. Many are working to develop registries (some using wearable technologies or apps) and natural history studies, which means that ever-greater volumes of data are being produced.

Trials 105

Trials Clinical Trials Clinical Trials Life Science 105

ACRP blog

JUNE 13, 2024

by Steve Young, MA, Chief Scientific Officer at CluePoints. “The Evolution of Access: A Pathway to Multiple Markets,” by Piety Rocha, Director, Head of Regulatory Affairs & Country VDC Head at PharmaLex, Australia. “Establishing Early Efficacy in Depression Clinical Trials,” by Bradley D.

Clinical Research 59

Clinical Research Research Clinical Trials Clinical Trials 59

pharmaphorum

MAY 30, 2022

The company developed the first FDA-authorised at-home VR pain treatment, RelieVRx, indicated as an adjunctive treatment for chronic lower back pain. He oversees operations, including business development, sales and marketing, and people. Distinct offerings. AppliedVR creates VR-based treatments aimed at relieving chronic pain.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

pharmaphorum

DECEMBER 22, 2021

In addition, we created Patient Partnerships and highlighted that we ‘pay’ our Patient Board Members a fair market value that recognises their ‘lived experience expertise’ in consulting with us – with our pharma clients – to recommend strategies for enduring patient engagement. Rise of the machines – big data, AI and machine learning.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Pharma Companies 105

pharmaphorum

JULY 4, 2022

Alongside technical issues, compliance with data protection regulations, pseudo- and anonymisation of data, ethical and legal issues, patient’s consent, and local governmental policies pose additional elements that must be addressed and might differ between the countries, impacting international data sharing.

Genome 105

Genome Genomics Research Medicine 105

ACRP blog

JUNE 13, 2024

by Steve Young, MA, Chief Scientific Officer at CluePoints. “The Evolution of Access: A Pathway to Multiple Markets,” by Piety Rocha, Director, Head of Regulatory Affairs & Country VDC Head at PharmaLex, Australia. “Establishing Early Efficacy in Depression Clinical Trials,” by Bradley D.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

ACRP blog

JUNE 13, 2024

by Steve Young, MA, Chief Scientific Officer at CluePoints. “The Evolution of Access: A Pathway to Multiple Markets,” by Piety Rocha, Director, Head of Regulatory Affairs & Country VDC Head at PharmaLex, Australia. “Establishing Early Efficacy in Depression Clinical Trials,” by Bradley D.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52